DV
Dividend Vision

DGNOF Stock — DIAGNOS Inc

DIAGNOS Inc (DGNOF)

Updated October 16, 2026.

DGNOF is a Stock. Total return is -83.1% over the past 23.3 years, 1166.2 points behind SPY at 1083.1%.

DIAGNOS Inc. is a Canadian healthcare software company that develops web-based tools for detecting diabetic retinopathy and other retinal conditions, along with data analysis and artificial intelligence consulting services. The company does not currently distribute dividends to shareholders. This security appeals to investors seeking equity exposure to specialized healthcare technology rather than income-focused investors.

DGNOF dividend yield and income

Price as of 2026-10-16.

The payment date is 04/24/2019.

DGNOF performance versus SPY

Price and return data through 2026-10-16.

Total return is -83.1% over the past 23.3 years, 1166.2 points behind SPY at 1083.1%. Over the past year its total return — price change plus distributions reinvested — is 0.0%. Its deepest 1-year drawdown was 51.9%.

WindowTotal returnCAGR
1M-20.3%—
3M62.7%—
6M50.0%—
YTD3.9%—
1Y0.0%—
2Y CAGR—6.10%
3Y CAGR—-8.30%
5Y CAGR—-7.60%
Since inception (23.3 years)-83.1%-7.30%

DGNOF key facts

Asset type
Stock
Asset class
Equity
Inception date
06/24/2003
Distribution frequency
None
Last close
$0.27 (as of 2026-10-16)
Market cap
$32,680,138
Average volume
4000.0
Payment date
04/24/2019
Beta
0.079
Payout ratio
0.0%
Forward P/E
10.3627
EPS
$-0.03

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

DGNOF risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 51.9%.

Who may consider DGNOF — and who may not

It is a weaker fit for investors who need monthly cash flow (DGNOF does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on DGNOF

Tagged: Healthcare.

Frequently asked questions

Does DGNOF pay monthly?

No. DGNOF does not currently distribute.

When does DGNOF pay a dividend?

DGNOF does not currently distribute. The payment date is 04/24/2019.

How has DGNOF performed?

Total return is -83.1% over the past 23.3 years, 1166.2 points behind SPY at 1083.1%. Over the past year its total return — price change plus distributions reinvested — is 0.0%. Its deepest 1-year drawdown was 51.9%.

DividendVision analysis is generated from public SEC filing data and may not capture every change. Review the original filing for complete information.